Biotechnology Stocks I Performance Guide: Novavax, Inc. (NVAX)
NVAX has no dividends.
Table and Chart of NVAX Performance
See what a $1,000 investment in NVAX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| NVAX Returns | |
|---|---|
| Start Date | Oct-31-2014 |
| Start Price | $112.00 |
| End Date | Oct-11-2024 |
| End Price | $12.53 |
| # Prices | 121 |
| Min Date | Dec-31-2019 |
| Min Price | $3.98 |
| Max Date | Jul-31-2015 |
| Max Price | $241.20 |
| Total Return | -88.81% |
| Annualized Return | -19.53% |
| Current Value of $1,000 Purchase | $112 |
| Number Returns | 7,260 |
| Average Return | 113.48% |
| Number Profitable Returns | 2,425 |
| Percent Profitable Returns | 33.40% |
| Number Unprofitable Returns | 4,835 |
| Percent Unprofitable Returns | 66.60% |
| Profitable to Unprofitable Returns Ratio | 0.50 |
| NVAX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -0.534 | Price to Sales | 1.78 |
| Earnings per Share | $0.0000 |
| PE Ratio | -240839008 |
| PE to Growth Ratio | None |
| Price to Book | 2.031 |
| PRICE DATA | |
| 52 Week High | $2.033 |
| 52 Week Low | $23.86 |
| Analyst Target Price | $-0.021 |
| 50-Day Moving Average | $3.532 |
| 200-Day Moving Average | $12.46 |
| FINANCIAL DATA | |
| Revenue per Share | $-2.62 |
| Revenue | $-9 |
| Profit Margin | 766% |
| Return on Equity | -10.2% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
NVAX Compare Returns with S&P 500
NVAX Trendline Chart
NVAX Moving Average Chart
NVAX Stock Return Map - See Patterns of Gains and Losses
NVAX Stock Returns/Purchase Dates